Assessing patient beliefs in a clinical trial ofHypericum perforatum in major depression

2004 ◽  
Vol 20 (3) ◽  
pp. 114-122 ◽  
Author(s):  
Carla M. Bann ◽  
Corette B. Parker ◽  
Jacques Bradwejn ◽  
Jonathan R.T. Davidson ◽  
Benedetto Vitiello ◽  
...  



2000 ◽  
Vol 21 ◽  
pp. 243 ◽  
Author(s):  
Constantine George Lyketsos ◽  
Jeannie-Marie E. Sheppard ◽  
Cynthia D. Steele ◽  
Susan Kopunke ◽  
Alva S. Baker ◽  
...  




2008 ◽  
Vol 69 (8) ◽  
pp. 1276-1280 ◽  
Author(s):  
Carlos Blanco ◽  
Mark Olfson ◽  
Renee D. Goodwin ◽  
Elizabeth Ogburn ◽  
Michael R. Liebowitz ◽  
...  


1996 ◽  
Vol 168 (1) ◽  
pp. 38-42 ◽  
Author(s):  
Michael Kerfoot ◽  
Elizabeth Dyer ◽  
Val Harrington ◽  
Adrine Woodham ◽  
Richard Harrington

BackgroundThe features of adolescents who had taken an overdose were assessed to determine the focus for a treatment trial.MethodOverdose cases were compared with psychiatric and community controls who had not taken an overdose in respect of mental disorders and family background.ResultsOverdose cases had high rates of major depression, but most of them recovered from depression within six weeks of the overdose. There was a specific association between taking an overdose and family dysfunction.ConclusionsFamily dysfunction could be a useful focus in a clinical trial of the aftercare of adolescents who have taken an overdose.



Sign in / Sign up

Export Citation Format

Share Document